The bill - introduced by U.S. Sen. Kirsten Gillibrand (D-NY) and U.S. Sen. Cory Gardner (R-CO) - would help prevent addiction and abuse, and help prevent opioids from falling into the wrong hands.
NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement.
NACDS and NCPA held a briefing this week on DIR fee reform for the Congressional Doctors Caucus. The Caucus is comprised of 16 medical providers in Congress who use their medical expertise to develop patient-centered healthcare policy.
Rep. Cathy McMorris Rodgers (R-WA), a consistently pro-pharmacy advocate, led a letter to Health and Human Services Secretary Alex Azar urging support for DIR fee reform.
NACDS and the National Community Pharmacists Association (NCPA) today praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar.
NACDS is urging support for a bipartisan Senate letter to Health and Human Services Secretary Alex Azar on DIR fee reform.
NACDS attended a conference this week hosted by Rep. Markwayne Mullin (R-OK) lauding the passage of new opioid legislation.
Lawmakers back in their congressional districts while Congress is on recess got to see the valuable services pharmacists provide to their constituents every day.
NACDS applauded the Trump Administration’s focus on reducing patients’ out-of-pocket drug costs, and Congressional sponsors’ effectiveness in advancing the "gag clause" ban. NACDS noted that pharmacy is a long-standing and trusted partner in helping patients achieve prescription-drug affordability – which is essential for health and wellness.
Legislation headed to President’s desk bears pharmacists’ insights from front lines of care, reflects pharmacy’s commitment as part of the solution to abuse.